2012
ADHD medication use following FDA risk warnings.
Barry CL, Martin A, Busch SH. ADHD medication use following FDA risk warnings. The Journal Of Mental Health Policy And Economics 2012, 15: 119-25. PMID: 23001280, PMCID: PMC3896970.Peer-Reviewed Original Research
2003
Trends in Psychotropic Medication Costs for Children and Adolescents, 1997-2000
Martin A, Leslie D. Trends in Psychotropic Medication Costs for Children and Adolescents, 1997-2000. JAMA Pediatrics 2003, 157: 997-1004. PMID: 14557161, DOI: 10.1001/archpedi.157.10.997.Peer-Reviewed Original ResearchConceptsCostly medicationsSelective serotonin reuptake inhibitorsPsychotropic medication costsPsychotropic medication utilizationSerotonin reuptake inhibitorsWarrants further studyMental health outpatientsMedication utilizationAtypical antidepressantsAtypical antipsychoticsPharmacy claimsReuptake inhibitorsMedication costsPsychotropic drugsDrug categoriesMedicationsNational databaseDrugsOverall useFurther studiesChildrenPrescription pricesAntipsychoticsAntidepressantsOutpatientsPsychiatric Inpatient, Outpatient, and Medication Utilization and Costs Among Privately Insured Youths, 19972000
Martin A, Leslie D. Psychiatric Inpatient, Outpatient, and Medication Utilization and Costs Among Privately Insured Youths, 19972000. American Journal Of Psychiatry 2003, 160: 757-764. PMID: 12668366, DOI: 10.1176/appi.ajp.160.4.757.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdolescent Health ServicesAge FactorsAmbulatory CareChildDrug CostsDrug UtilizationFemaleHealth Benefit Plans, EmployeeHealth Care CostsHealth Care SurveysHospitalizationHumansInsurance, PsychiatricLength of StayMaleManaged Care ProgramsMental DisordersMental Health ServicesPsychotropic DrugsUnited StatesUtilization ReviewConceptsOutpatient visitsPsychotropic medicationsProportion of youthOutpatient mental health servicesAnxiety disordersMedication-related costsOutpatient treatment modalityUse of inpatientTreatment of depressionInpatient psychiatric admissionAnalysis of inpatientMental health servicesAge 17 yearsAnnual utilization ratesMedication utilizationPharmacy claimsOutpatient costsTreatment modalitiesPsychiatric admissionsAnnual inpatientAdjustment disorderInpatient daysInpatientsHealth servicesPsychiatric inpatients
2000
The use of psychotropic medications in young children: the facts, the controversy, and the practice.
Stubbe DE, Martin A. The use of psychotropic medications in young children: the facts, the controversy, and the practice. Connecticut Medicine 2000, 64: 329-33. PMID: 10909194.Peer-Reviewed Original Research
1999
Higher-Functioning Pervasive Developmental Disorders: Rates and Patterns of Psychotropic Drug Use
MARTIN A, SCAHILL L, KLIN A, VOLKMAR F. Higher-Functioning Pervasive Developmental Disorders: Rates and Patterns of Psychotropic Drug Use. Journal Of The American Academy Of Child & Adolescent Psychiatry 1999, 38: 923-931. PMID: 10405512, DOI: 10.1097/00004583-199907000-00024.Peer-Reviewed Original ResearchConceptsPsychotropic drug useHigher-functioning pervasive developmental disordersPervasive developmental disorderTarget symptomsDrug useMedication use patternsPsychotropic medication useDevelopmental disordersMedication history informationMore medicationsMedication useClinical presentationPsychiatric comorbidityClinical variablesPsychotropic agentsDrug classesClinical heterogeneityDisordersSymptomsSubjectsAsperger's disorderFull Scale IQComorbiditiesMedicationsAntidepressants